Literature DB >> 22645634

Analysis of liver metastasis after resection for pancreatic ductal adenocarcinoma.

Kwang Yeol Paik1, Seong Ho Choi, Jin Seok Heo, Dong Wook Choi.   

Abstract

AIM: To investigate the risk factors affecting the liver metastasis (LM) of pancreatic ductal adenocarcinoma (PDAC) after resection.
METHODS: We retrospectively analyzed 101 PDAC patients who underwent surgical resection at the Samsung Medical Center between January 2000 and December 2004. Forty one patients with LM were analyzed for the time of metastasis, prognostic factors affecting LM, and survival.
RESULTS: LM was found in 40.6%. The median time of the LM (n = 41) was 6.0 ± 4.6 mo and most LM occurred within 1 year. In univariate analysis, tumor size, preoperative carbohydrate antigen 19-9, and perineural invasion were factors affecting LM after resection. In multivariate analysis, tumor size was the most important factor for LM. In univariate analysis, tumor cell differentiation was significant to LM in low-risk groups.
CONCLUSION: LM after resection of PDAC occurs early and shows poor survival. Tumor size is the key indicator for LM after resection.

Entities:  

Keywords:  Liver metastasis; Pancreatic ductal adenocarcinoma; Recurrence

Year:  2012        PMID: 22645634      PMCID: PMC3360104          DOI: 10.4251/wjgo.v4.i5.109

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  31 in total

1.  Treatment of locoregional recurrence after intentional curative resection of pancreatic cancer.

Authors:  M B Menke-Pluymers; J H Klinkenbijl; M Tjioe; J Jeekel
Journal:  Hepatogastroenterology       Date:  1992-10

2.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

3.  Surgery for recurrent pancreatic ductal adenocarcinoma.

Authors:  Jörg Kleeff; Carolin Reiser; Ulf Hinz; Jeannine Bachmann; Jürgen Debus; Dirk Jaeger; Helmut Friess; Markus W Büchler
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

4.  Regional celiac artery infusion as adjuvant treatment after pancreatic cancer resection.

Authors:  K H Link; A Formentini; F Gansauge; E Papachristov; H G Beger
Journal:  Digestion       Date:  1997       Impact factor: 3.216

5.  Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma.

Authors:  Shinichiro Takahashi; Takahiro Hasebe; Tatsuya Oda; Satoshi Sasaki; Taira Kinoshita; Masaru Konishi; Takenori Ochiai; Atsushi Ochiai
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

6.  Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.

Authors:  Saburo Fukuda; Elie Oussoultzoglou; Philippe Bachellier; Edoardo Rosso; Hiroshi Nakano; Maxime Audet; Daniel Jaeck
Journal:  Arch Surg       Date:  2007-02

7.  Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.

Authors:  Axel Richter; Marco Niedergethmann; Jörg W Sturm; Dietmar Lorenz; Stefan Post; Michael Trede
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

8.  Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.

Authors:  Yu-Jun Li; Yun-Xiao Meng; Xiang-Rui Ji
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2003-08

9.  Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.

Authors:  E Papachristou; K H Link; M H Schoenberg
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

10.  The time of occurrence of liver metastasis in carcinoma of the pancreas.

Authors:  K Amikura; M Kobari; S Matsuno
Journal:  Int J Pancreatol       Date:  1995-04
View more
  10 in total

1.  An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer.

Authors:  Justin A Kenkel; William W Tseng; Matthew G Davidson; Lorna L Tolentino; Okmi Choi; Nupur Bhattacharya; E Scott Seeley; Daniel A Winer; Nathan E Reticker-Flynn; Edgar G Engleman
Journal:  Cancer Res       Date:  2017-06-13       Impact factor: 12.701

2.  Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.

Authors:  Courey Averett; Arun Bhardwaj; Sumit Arora; Sanjeev K Srivastava; Mohammad Aslam Khan; Aamir Ahmad; Seema Singh; James E Carter; Moh'd Khushman; Ajay P Singh
Journal:  Carcinogenesis       Date:  2016-11-01       Impact factor: 4.944

3.  Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo.

Authors:  Muayad Almahariq; Celia Chao; Fang C Mei; Mark R Hellmich; Igor Patrikeev; Massoud Motamedi; Xiaodong Cheng
Journal:  Mol Pharmacol       Date:  2014-11-10       Impact factor: 4.436

4.  Multimodality treatment of recurrent pancreatic cancer: Mith or reality?

Authors:  Cosimo Sperti; Lucia Moletta; Stefano Merigliano
Journal:  World J Gastrointest Oncol       Date:  2015-12-15

Review 5.  Pancreatic cancer metastasis: are we being pre-EMTed?

Authors:  Srustidhar Das; Surinder K Batra
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered.

Authors:  Pedro Luiz Serrano Usón Junior; Monique Sedlmaier França; Heloisa Veasey Rodrigues; Antônio Luiz de Vasconcellos Macedo; Alberto Goldenberg; Oren Smaletz; Daniela Pezzutti Domingues Armentano; Sergio Daniel Simon; Rene Claudio Gansl
Journal:  Einstein (Sao Paulo)       Date:  2015-08-21

7.  Instantaneous mutation rate in cancer initiation and progression.

Authors:  Shuhao Sun; Fima Klebaner; Xinan Zhang; Tianhai Tian
Journal:  BMC Syst Biol       Date:  2018-11-22

8.  The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.

Authors:  Hong Luan; Ye He; Tuo Zhang; Yanna Su; Liping Zhou
Journal:  BMC Cancer       Date:  2022-04-27       Impact factor: 4.638

9.  A Comparative Study of Survivor Outcomes between Preoperative Evaluation Using CT Alone and Combined CT and MRI in Patients with Pancreatic Ductal Adenocarcinoma.

Authors:  Ji Eun Lee; Seong Hyun Kim; Soon Jin Lee; Seo-Youn Choi; Sunyoung Lee; Bo Ra Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-02-28

10.  Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer - DIA-PANC study: study protocol for an international, multicenter, diagnostic trial.

Authors:  G Litjens; D M Rivière; E J M van Geenen; S A Radema; L A A Brosens; M Prokop; C J H M van Laarhoven; J J Hermans
Journal:  BMC Cancer       Date:  2020-08-10       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.